Dukagjin Blakaj

Associate Professor

Ohio State University

United States

Research Interests

Explore related searches

Professors in United States Professors in Medical Imaging Medical Imaging professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Dukagjin Blakaj is an Associate Professor at Ohio State University in the United States. His research focuses on radiotherapy, particularly in the treatment of head and neck cancers, brain metastases, and the assessment of image quality in MRI. He has published extensively on topics including the prediction of treatment outcomes in HPV-positive oropharyngeal cancer and disparities in survival outcomes among racial and ethnic minorities.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Collaborators (3)

Joshua D. Palmer

UNITED STATES

View details

Evan Thomas

Assistant Professor

UNITED STATES

View details

Darrion Mitchell

The Ohio State University Wexner Medical Center

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Dukagjin Blakaj

Research Interests

Explore related searches

Contact this professor

About

Articles (10)

18F-FDG PET/CT Prediction of Treatment Outcomes in Human Papillomavirus-Positive, Locally Advanced Oropharyngeal Cancer Patients Receiving Deintensified Therapy: Results from NRG-HN002

Advances in Radiotherapy for Brain Metastases

Assessment of MRI image distortion based on 6 consecutive years of annual QAs and measurements on 14 MRI scanners used for radiation therapy

Comparing pre-operative versus post-operative single and multi-fraction stereotactic radiotherapy for patients with resectable brain metastases

Comparison of Gonadal Toxicity of Single-Fraction Ultra-High Dose Rate and Conventional Radiation in Mice

Disparities in Survival Outcomes among Racial/Ethnic Minorities with Head and Neck Squamous Cell Cancer in the United States

Disparities in survival outcomes among Black patients with HPV-associated oropharyngeal cancer

Implementation of triggered kilovoltage imaging for stereotactic radiotherapy of the spine for patients with spinal fixation hardware

PREVLAR: Phase 2a Randomized Trial to Assess the Safety and Efficacy of RRx-001 in the Attenuation of Oral Mucositis in Patients Receiving Head and Neck Chemoradiotherapy

Safety of Nivolumab Added to Chemoradiation Therapy Platforms for Intermediate and High-Risk Locoregionally Advanced Head and Neck Squamous Cell Carcinoma: RTOG Foundation 3504

Collaborators (3)

Joshua D. Palmer

Evan Thomas

Darrion Mitchell

Make your next move.